- Home
- MYND vs CTOR Comparison
MYND vs CTOR Comparison
Compare MYND & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- CTOR
- Stock Information
- Founded
- MYND 1998
- CTOR 2021
- Country
- MYND Cayman Islands
- CTOR United States
- Employees
- MYND N/A
- CTOR N/A
- Industry
- MYND Other Consumer Services
- CTOR
- Sector
- MYND Real Estate
- CTOR
- Exchange
- MYND Nasdaq
- CTOR NYSE
- Market Cap
- MYND 85.8M
- CTOR 89.9M
- IPO Year
- MYND 2017
- CTOR N/A
- Fundamental
- Price
- MYND $1.67
- CTOR $1.27
- Analyst Decision
- MYND
- CTOR Strong Buy
- Analyst Count
- MYND 0
- CTOR 2
- Target Price
- MYND N/A
- CTOR $4.50
- AVG Volume (30 Days)
- MYND 62.0K
- CTOR 171.0K
- Earning Date
- MYND 02-05-2025
- CTOR 02-21-2025
- Dividend Yield
- MYND N/A
- CTOR N/A
- EPS Growth
- MYND N/A
- CTOR N/A
- EPS
- MYND N/A
- CTOR N/A
- Revenue
- MYND $357,050,000.00
- CTOR N/A
- Revenue This Year
- MYND N/A
- CTOR N/A
- Revenue Next Year
- MYND N/A
- CTOR N/A
- P/E Ratio
- MYND N/A
- CTOR N/A
- Revenue Growth
- MYND N/A
- CTOR N/A
- 52 Week Low
- MYND $0.01
- CTOR $0.85
- 52 Week High
- MYND $5.57
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- MYND 41.35
- CTOR N/A
- Support Level
- MYND $1.50
- CTOR N/A
- Resistance Level
- MYND $1.78
- CTOR N/A
- Average True Range (ATR)
- MYND 0.24
- CTOR 0.00
- MACD
- MYND -0.04
- CTOR 0.00
- Stochastic Oscillator
- MYND 13.39
- CTOR 0.00
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.